$Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study$

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

Abstract Idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) have revolutionized the treatment of relapsed/refractory multiple myeloma (RRMM), but direct comparisons are lacking. Leveraging an international multicenter RRMM cohort, we compared the outcome of ide‐cel (n = 162)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maximilian Merz, Anca‐Maria Albici, Bastian vonTresckow, Kristin Rathje, Roland Fenk, Tobias Holderried, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Vladan Vucinic, Soraya Kharboutli, Ben‐Niklas Bärmann, Francis Ayuk, Uwe Platzbecker, Friedrich Stölzel, Nathalie Schub, Friederike Schmitz, David Fandrei, Patrick Born, Cyrus Khandanpour, Christine Hanoun, Keven Hörster, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Carlos Fernández de Larrea, Thomas Pabst, Nico Gagelmann
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	HemaSphere
Online Access:	https://doi.org/10.1002/hem3.70070
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma
by: Djordje Atanackovic, et al.
Published: (2025-07-01)

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
by: Satabdi Saha, et al.
Published: (2025-07-01)

Intrathecal chemotherapy for ciltacabtagene autoleucel–associated movement and neurocognitive toxicity
by: Kaitlin Kelly, et al.
Published: (2025-07-01)

Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
by: Aaron Trando, et al.
Published: (2024-12-01)

Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma
by: Danai Dima, et al.
Published: (2025-07-01)

Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy
by: Goel U, et al.
Published: (2025-02-01)

Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia
by: Ying Wang, et al.
Published: (2025-02-01)

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement
by: Ibrahim N. Muhsen, et al.
Published: (2025-08-01)

Safety and clinical efficacy of Relmacabtagene autoleucel (relma-cel) for systemic lupus erythematosus: a phase 1 open-label clinical trialResearch in context
by: Jinhui Shu, et al.
Published: (2025-05-01)

USING STATISTICAL SURVEY IN ECONOMICS
by: Delia TESELIOS, et al.
Published: (2012-01-01)

Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
by: Gaurav Narula, et al.
Published: (2025-04-01)

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
by: Gaurav Narula, et al.
Published: (2025-05-01)

A decomposition approach for integrated locomotive scheduling and driver assignment in rail freight transport
by: Andreas Bärmann, et al.
Published: (2024-01-01)

REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY
by: Ulrike Bacher, et al.
Published: (2021-01-01)

Epidemiological Study of Hepatitis B, C and HIV Cases among the Foreigners Visiting Sulaimani City from 2013 Through 2016
by: Mohammed Omer Mohammed, et al.
Published: (2019-10-01)

A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
by: Alfred L. Garfall, et al.
Published: (2025-07-01)

Adrenal myelolipoma: Radiologic-pathologic correlation
by: Ashish Sachan, et al.
Published: (2018-01-01)

A CAD/CAM Zirconium Bar as a Bonded Mandibular Fixed Retainer: A Novel Approach with Two-Year Follow-Up
by: Maen Zreaqat, et al.
Published: (2017-01-01)

What’s Going On With Me and How Can I Better Manage My Health? The Potential of GPT-4 to Transform Discharge Letters Into Patient-Centered Letters to Enhance Patient Safety: Prospective, Exploratory Study
by: Felix Eisinger, et al.
Published: (2025-01-01)

Paternal Split‐Liver Transplantation Followed by Haploidentical Hematopoietic Cell Transplantation in an Adult Patient With Protoporphyria‐Induced Liver Failure
by: Ulrich Stölzel, et al.
Published: (2025-02-01)

Phylogenetic Assessment of Gazella bennettii: A Genetic Framework for the Conservation of the Endangered Jebeer in Iran
by: Davoud Fadakar, et al.
Published: (2025-02-01)

Development of a modular patient-reported outcome and experience measure on patient needs and benefits in CLL (PBI-CLL)
by: Beke Hester, et al.
Published: (2025-04-01)

Fast-timing spectroscopy with the ν-ball2 spectrometer
by: Pascu S., et al.
Published: (2025-01-01)

Cross-modulation of homeostatic responses to temperature, oxygen and carbon dioxide in C. elegans.
by: Eiji Kodama-Namba, et al.
Published: (2013-01-01)

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients
by: Christina Rautenberg, et al.
Published: (2025-04-01)

Long non-coding RNA LINC00926 is a biomarker for naïve B-cells with prognostic value in advanced stage classic Hodgkin Lymphoma
by: Ingram Iaccarino, et al.
Published: (2025-07-01)

Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
by: Lukas D. Uleer, et al.
Published: (2025-06-01)

Oxidation of some Alicyclic Amines by Potassium Hexacyanoferrate (III) in Alkaline Medium: A Kinetic and Mechanistic Study
by: M. M. Al-Subu, et al.
Published: (2001-06-01)

Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma
by: Patrick Born, et al.
Published: (2025-06-01)

ROS and cGMP signaling modulate persistent escape from hypoxia in Caenorhabditis elegans.
by: Lina Zhao, et al.
Published: (2022-06-01)

A decade of DesignSafe: enabling open science in natural hazards
by: Ellen M. Rathje, et al.
Published: (2025-07-01)

Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies
by: Ulrike Weirauch, et al.
Published: (2025-08-01)

Problem-based training improves recognition of patient hazards by advanced medical students during chart review: a randomized controlled crossover study.
by: Friederike Holderried, et al.
Published: (2014-01-01)

Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
by: Nico Gagelmann, et al.
Published: (2025-06-01)

Microbiological profile and antibiotic susceptibility of body fluids or swabs of acute leukemia patients with sepsis in a tertiary care hospital
by: Arka Karmakar, et al.
Published: (2025-07-01)

Assessing the quality of medication documentation: development and feasibility of the MediDocQ instrument for retrospective chart review in the hospital setting
by: Tanja Manser, et al.
Published: (2019-11-01)

Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis
by: Mathias Schäfersküpper, et al.
Published: (2025-01-01)

Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia
by: Leo Ruhnke, et al.
Published: (2025-03-01)

Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN
by: Aude Servais, et al.
Published: (2024-12-01)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
by: Anna Lena Platzbecker, et al.
Published: (2025-04-01)